Secondary prevention of vascular disease by prolonged antiplatelet treatment
暂无分享,去创建一个
K. McPherson | Jennifer | G. Davey | B. Farrell | Joseph | Pat. | B. Hafner | A. Lawson | C. Bates | Simpson | M. Tinker | M. Goulding | J. Kench | J. McVitie | Jill Ratcliff | Stewart R Williams
[1] V. Hachinski,et al. THE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE , 1989, The Lancet.
[2] M. Bousser,et al. Prévention secondaire des accidents ischémiques cérébraux , 1989 .
[3] B. Rabinowitz,et al. [Aspirin in coronary heart disease]. , 1989, Harefuah.
[4] J. Grotta. Current medical and surgical therapy for cerebrovascular disease. , 1987, The New England journal of medicine.
[5] Isis Pilot Study Investigation. Randomized factorial trial of high-dose intravenous streptokinase, of oral aspirin and of intravenous heparin in acute myocardial infarction , 1987 .
[6] L. Wilkins. High-dose acetylsalicylic acid after cerebral infarction. A Swedish Cooperative Study. , 1987, Stroke.
[7] J. Cutler,et al. The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. , 1986, Progress in cardiovascular diseases.
[8] C. Patrono. Aspirin for the prevention of coronary thrombosis: current facts and perspectives. , 1986, European heart journal.
[9] G. Boysen,et al. Effect of incremental doses of aspirin on bleeding time, platelet aggregation and thromboxane production in patients with cerebrovascular disease , 1985, European journal of clinical investigation.
[10] G. Davı̀,et al. Clinical pharmacology of platelet cyclooxygenase inhibition. , 1985, Circulation.
[11] D. Sackett,et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a Canadian multicenter trial. , 1985, The New England journal of medicine.
[12] M. Stampfer,et al. Cumulative antiplatelet effect of low‐dose enteric coated aspirin , 1985, British journal of haematology.
[13] C. Bulpitt,et al. Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial , 1985, The Lancet.
[14] H. Barnett,et al. A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. , 1985, Stroke.
[15] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[16] A. Einstein,et al. Persantine Aspirin Trial in cerebral ischemia. Part II: Endpoint results. The American-Canadian Co-Operative Study group. , 1985, Stroke.
[17] C. Hennekens,et al. A randomized trial of aspirin and beta-carotene among U.S. physicians. , 1985, Preventive medicine.
[18] P. Weber,et al. IMPROVED AORTOCORONARY BYPASS PATENCY BY LOW-DOSE ASPIRIN (100 mg DAILY) Effects on Platelet Aggregation and Thromboxane Formation , 1984, The Lancet.
[19] G. Boysen,et al. Prolongation of Bleeding Time and Inhibition of Platelet Aggregation by Low-Dose Acetylsalicylic Acid in Patients With Cerebrovascular Disease , 1984, Stroke.
[20] W. Hass,et al. The North American ticlopidine aspirin stroke study: structure, stratification variables, and patient characteristics. , 1984, Agents and actions. Supplements.
[21] M. LeWinter,et al. Protective effects of aspirin against acute myocardial infarction and death in men with unstable angina. Results of a Veterans Administration Cooperative Study. , 1983, The New England journal of medicine.
[22] P. Sørensen,et al. Acetylsalicylic acid in the prevention of stroke in patients with reversible cerebral ischemic attacks. A Danish cooperative study. , 1983, Stroke.
[23] Aspirin in coronary heart disease. Comparison of six clinical trials. , 1983, Israel journal of medical sciences.
[24] P. Touboul,et al. "AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. , 1983, Stroke.
[25] P. Elwood. Trial of acetylsalicylic acid in the secondary prevention of mortality from myocardial infarction. , 1981, British medical journal.
[26] Persantine‐Aspirin Reinfarction Study: Design, Methods and Baseline Results , 1980, Circulation.
[27] P. Glasziou. Aspirin after Myocardial Infarction , 1980, The Lancet.
[28] K. Uberla,et al. Secondary prevention of myocardial infarction: a comparison of acetylsalicylic acid, placebo and phenprocoumon. , 1980, Haemostasis.
[29] R. Hardy,et al. A CONTROLLED TRIAL OF ASPIRIN IN CEREBRAL ISCHAEMIA , 1980, Circulation.
[30] A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. , 1980, JAMA.
[31] Sulfinpyrazone in the prevention of sudden death after myocardial infarction. , 1980, The New England journal of medicine.
[32] P. Elwood,et al. ASPIRIN AND SECONDARY MORTALITY AFTER MYOCARDIAL INFARCTION , 1979, The Lancet.
[33] J. Blakely. A Prospective Trial of Sulfinpyrazone and Survival After Thrombotic Stroke , 1979 .
[34] R. Huyke,et al. [Prevention of reinfarction with acetylsalicylic acid]. , 1979, Folia haematologica.
[35] A randomized trial of aspirin and sulfinpyrazone in threatened stroke. , 1978, The New England journal of medicine.
[36] R. Hardy,et al. Controlled Trial of Aspirin in Cerebral Ischemia , 1977, Stroke.
[37] P C Elwood,et al. A Randomized Controlled Trial of Acetyl Salicyclic Acid in the Secondary Prevention of Mortality from Myocardial Infarction , 1974, British medical journal.
[38] C. V. von Essen. The Treatment of Cancer , 1966, Nature.